In the whole cohort, low RPA1 was associated with poor outcome in terms of shorter breast cancer-specific survival (BCSS) (P < 0.0001) (Fig. 1D) and distant metastasis-free survival (DMFS) (P < 0.0001) (Supplementary Fig. 1A). The gene discussed is RPA1; the disease is breast carcinoma.